JULIE KOO: Open Payments
NPI 1265172332 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 14 payments from 7 companies in 2025. Trend: 2023 $148 · 2024 $274 · 2025 $1,451
Food & beverage: $917Travel & lodging: $535
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $844 |
| Ipsen Biopharmaceuticals, Inc | 3 | $161 |
| Madrigal Pharmaceuticals | 2 | $141 |
| Janssen Biotech, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $117 |
| Olympus America Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $23 |
Products named: General - Therapies, REZDIFFRA, Bylvay, TREMFYA, IQIRVO, VISIGLIDE, CREON, Single Use Electrosurgical Snare SD-400.
Industry payments across TX — which companies pay providers there.
